Insulin Access: Kevin's Law
Three Reasons Why is Insulin STILL So Expensive
29 Aug 2023, 4:49 p.m. in Contains: Resource, Country: Global, Insulin Access: Alec's Law, Insulin Access: Kevin's Law, Insulin Access: Modern Insulins, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform, Taking on Monopoly Power: Public Pharma by Shaina Kasper
Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more
Categories
- Action & Workshop
- Contains: Resource
- Content Type: Advocacy Stories
- Content Type: Interviews
- Content Type: News & Statements
- Country: Brazil
- Country: Democratic Republic of Congo
- Country: Egypt
- Country: France
- Country: Global
- Country: Hungary
- Country: India
- Country: Kenya
- Country: Nigeria
- Country: Pakistan
- Country: Palestine
- Country: Panama
- Country: Sierra Leone
- Country: South Africa
- Country: Tanzania
- Country: United States
- Country: Uruguay
- Country: Zimbabwe
- Insulin Access: Alec's Law
- Insulin Access: Kevin's Law
- Insulin Access: Modern Insulins
- Insulin Access: Price Caps
- Organizational Updates
- Research
- Taking on Monopoly Power: Patent Reform
- Taking on Monopoly Power: Public Pharma
- The Right to Full Care: Combatting Discrimination with Education
- The Right to Full Care: Diabetes in Humanitarian Settings
- The Right to Full Care: Glucose Self-Monitoring Supplies
- The Right to Full Care: Mental Health Care
- The Right to Full Care: Other Essential Medicine Access & Universal Health Coverage